NeuroBo Pharmaceuticals I...
(NRBO)
undefined
undefined%
At close: undefined
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
PE Ratio | -0.38 | -0.08 | -0.46 | -0.72 | -0.51 | -7.28 | -4.92 | -6.24 | -10.80 | -304.81 |
PS Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PB Ratio | 0.28 | 0.02 | 0.48 | 2.96 | 0.93 | -2.26 | 41.72 | 4.41 | -7.88 | -183.69 |
P/FCF Ratio | -0.43 | -0.04 | -0.47 | -1.98 | -1.58 | -7.86 | -6.11 | -8.25 | -17.95 | -500.20 |
P/OCF Ratio | -0.43 | -0.04 | -0.47 | -1.98 | -1.62 | -7.86 | -6.11 | -8.25 | -17.95 | -500.20 |
OCF/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 | 0.64 | 0.00 | -0.13 | -0.35 |
Quick Ratio | 0.94 | 0.71 | 1.92 | 0.72 | 1.70 | 0.50 | 0.74 | 1.50 | 0.10 | 0.09 |
Current Ratio | 0.94 | 0.71 | 1.92 | 0.72 | 1.70 | 0.50 | 0.74 | 1.50 | 0.10 | 0.09 |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage | 0.00 | -2.24 | 0.00 | -190.49 | -229.27 | -8.72 | 0.00 | 0.00 | 0.00 | 0.00 |
Return on Equity (ROE) | -74.74% | -28.11% | -104.28% | -410.84% | -182.48% | 30.96% | -847.88% | -70.70% | 72.93% | 60.26% |
Return on Assets (ROA) | -54.74% | -18.24% | -90.61% | -269.81% | -155.04% | -120.02% | -175.71% | -58.92% | -200.64% | -91.95% |
Return on Capital (ROIC) | -94.44% | -90.24% | -104.48% | -408.58% | -162.89% | -222.34% | -262.33% | -71.23% | 182.43% | 50.09% |
Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |